<?xml version="1.0" encoding="iso-8859-1"?>
<rss version="2.0">
  <channel>
    <title>RSS News Feed for MolecularMD - from Laboratorytalk</title>
    <link>http://www.laboratorytalk.com/news/moa/moa000.html</link>
    <description>MolecularMD news releases on Laboratorytalk</description>
    <language>en-gb</language>
    <copyright>Copyright (C)2008 Pro-Talk Ltd. All rights reserved.</copyright>
    <pubDate>Mon, 25 Aug 2008 08:00:00 UT</pubDate>
    <lastBuildDate>Mon, 25 Aug 2008 08:00:00 UT</lastBuildDate>
    <image>
      <title>Pro-Talk Ltd</title>
      <url>http://www.pro-talk.com/images/protalklogo90.gif</url>
      <link>http://www.pro-talk.com/</link>
      <width>90</width>
      <height>79</height>
    </image>
    <item>
      <title>Commercial rights to intellectual property</title>
      <description>MolecularMD has entered an agreement for exclusive rights to patented intellectual property related to the detection of Imatinib resistant BCR-ABL mutations</description>
      <pubDate>Fri, 30 May 2008 08:00:00 UT</pubDate>
      <category>MolecularMD</category>
      <link>http://www.laboratorytalk.com/news/moa/moa101.html</link>
    </item>
    <item>
      <title>MolecularMD to join CML Alliance programme</title>
      <description>MolecularMD is to participate as a preferred provider of Quantitative Reverse Transcription Polymerase Chain Reaction (qRT-PCR) patient monitoring tests for CML Alliance </description>
      <pubDate>Tue, 07 Aug 2007 08:00:00 UT</pubDate>
      <category>MolecularMD</category>
      <link>http://www.laboratorytalk.com/news/moa/moa100.html</link>
    </item>
  </channel>
</rss>
